What's breaking now, across thousands of outlets.
The acquisition gives the German company a promising blood disorder medicine that passed a Phase 2 test and could threaten a Takeda drug.
We haven't written up this one. BioPharma Dive has the full story — the link below goes straight to it.
Germany's Merck KGaA agreed to buy UK drug developer Silence Therapeutics for $1.3 billion, building out its work in rare and specialty diseases using genetic medicines.
Michael Lynch, from Men's Action Network (MAN) offered to meet the Derry City footballer James McClean.
A Russian attack on Kyiv on Oct. 19 damaged the Consultative and Diagnostic Center at Kyiv City Clinical Hospital No. 6 in the Solomianskyi district, forcing it to suspend operations, the Kyiv City…
Machine learning analysis reveals that different sensory experiences in autistic children correspond to unique patterns of brain connectivity.
The exercise, according to health officials, will cover girls aged between 9 to 14 years who have previously not received the vaccine.
Emiliano Martinez Chelsea goalkeeper Emiliano Martinez expects to return to action in a few weeks after undergoing successful surgery for a broken jaw.
